Nuvation Bio Inc. (NUVB) Form 424B5 — Jun 26, 2026
Nuvation Bio Inc. (NUVB) is offering $250 million in 0.75% Convertible Senior Notes due 2032, with an initial conversion price of approximately $7.84 per share. The company expects to receive net proceeds of approximately $241.2 million after deducting underwriting discounts and offering expenses. The company plans to use the proceeds to pay $14.9 million for capped call transactions, repay $58.5 million in obligations under its existing senior secured loan agreement, and fund general corporate purposes.
Key figures
- Total Debt
- 212947000
- Debt Amount
- 250000000
- Cash Position
- 533729000
- Interest Rate
- 0.75
- Maturity Date
- July 1, 2032
- Gross Proceeds
- 250000000
- Offering Price
- 100
- Conversion Price
- 7.84
- Capped Call Cost
- 14900000
- Shares Outstanding
- 347693331
- Stock Price At Filing
- 5.81
- Loan Repayment Amount
- 58500000
- Over Allotment Amount
- 37500000
- Financing Agreement Liability
- 159830000
Price after filing
Close on the filing date to close N calendar days later (from $5.81). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.